We observed a significant reduction in the chemokine CCL21, also referred to as secondary lymphoid tissue chemokine (SLC) and the ligand for CCR7-expressing cells (50), within E2-/- compared to control B6 lungs, both at homeostasis and after tumor seeding. The gene discussed is CCL21; the disease is neoplasm.